AiXin Life International, Inc. (AIXND)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
AiXin Life International, Inc. (AIXND). AiXin Life International, Inc. operates in China, marketing and selling nutritional consumer products and supplements. The company operates through advertising and product sales, pharmacies, and hotel operations. Sector: Consumer defensive.
Last analyzed: Mar 18, 2026AIXND: 1/1 perspectives are bearish.
How is this calculated? →AiXin Life International, Inc. (AIXND) Consumer Business Overview
AiXin Life International, Inc. is a China-based company focused on the distribution of nutritional consumer products and supplements through pharmacies, sales offices, and online channels, while also operating a hotel. Its negative profit and gross margins highlight significant challenges in a competitive market.
What Is the Investment Thesis for AIXND?
Investing in AiXin Life International, Inc. presents a high-risk, high-reward scenario. The company's negative profit margin of -153.1% and negative gross margin of -15.0% indicate significant operational inefficiencies. A potential turnaround hinges on improving profitability, streamlining operations, and capitalizing on growth opportunities within the Chinese consumer market. The company's beta of 3.74 suggests high volatility, making it suitable only for investors with a high-risk tolerance. Key catalysts include successful expansion of its online sales channels and improved performance of its hotel operations. However, the company's OTC listing and limited financial disclosure add to the investment risk.
Based on FMP financials and quantitative analysis
AIXND Key Highlights
- Market capitalization of $0.04 billion, indicating a micro-cap company.
- Negative P/E ratio of -1.96, reflecting current unprofitability.
- Profit margin of -153.1%, highlighting substantial operational challenges.
- Gross margin of -15.0%, indicating that the cost of goods sold exceeds revenue.
- Beta of 3.74, suggesting high volatility compared to the overall market.
Who Are AIXND's Competitors?
AIXND is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| EWOOF Eastwood Bio-Medical Canada Inc. | $0.69 | +0.00% | $47.79M | 45 |
| FRDZF Noumi Limited | $0.09 | +0.00% | $26.59M | 46 |
| LRKKF LARK Distilling Co. Ltd. | $0.62 | +0.00% | $67.02M | 49 |
| OISXF Oisix ra daichi Inc. | $9.97 | +33.47% | $346.29M | 64 |
| AVO Mission Produce, Inc. | $12.97 | +3.82% | $916.27M | 54 |
| BPPPF Bid Corporation Limited | $25.52 | +0.00% | $8.57B | 52 |
| UNFI United Natural Foods, Inc. | $46.32 | +1.65% | $2.80B | 50 |
| SPTN SpartanNash Company | $26.90 | +0.00% | $910.90M | 38 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are AIXND's Key Strengths?
- Established presence in the Chinese market.
- Diversified distribution channels.
- Operation of the Shangyan Hotel provides a diversified revenue stream.
- Focus on nutritional consumer products and supplements.
What Are AIXND's Weaknesses?
- Negative profit margin of -153.1%.
- Negative gross margin of -15.0%.
- Limited financial disclosure due to OTC listing.
- High beta of 3.74 indicates high volatility.
What Could Drive AIXND Stock Higher?
- Potential expansion of online sales channels by Q4 2026.
- Efforts to improve the performance of the Shangyan Hotel.
- Development of new nutritional products to meet evolving consumer demands.
- Strategic partnerships with pharmacies to expand distribution network by Q2 2027.
What Are the Key Risks for AIXND?
- Financial-distress signal — its Altman Z-Score of -9.52 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 1/9 flags soft profitability, leverage or efficiency.
- Negative profit margin of -153.1% indicates significant operational challenges.
- Negative gross margin of -15.0% suggests that the cost of goods sold exceeds revenue.
- Intense competition in the Chinese market could erode market share.
- Changing consumer preferences may impact demand for existing products.
- Limited financial disclosure due to OTC listing increases investment risk.
What Are the Growth Opportunities for AIXND?
- Expansion of Online Sales Channels: AiXin Life International can leverage the growing e-commerce market in China to expand its online sales channels. The Chinese e-commerce market is projected to reach $3.3 trillion in 2026. By investing in its online platform and digital marketing, the company can reach a wider customer base and increase sales. This initiative requires strategic partnerships with major e-commerce platforms and effective online marketing campaigns.
- Improvement of Hotel Operations: The Shangyan Hotel represents a potential growth opportunity for AiXin Life International. By improving the hotel's facilities, services, and marketing, the company can attract more customers and increase revenue. The Chinese tourism industry is expected to grow at a rate of 5% annually. Strategic renovations and targeted marketing campaigns could significantly boost the hotel's performance and contribute to overall profitability.
- Development of New Nutritional Products: AiXin Life International can invest in the research and development of new nutritional products and supplements to meet evolving consumer demands. The global nutritional supplements market is projected to reach $278 billion by 2028. By introducing innovative products that cater to specific health needs, the company can attract new customers and increase market share. This requires a strong focus on product innovation and quality control.
- Strategic Partnerships with Pharmacies: AiXin Life International can form strategic partnerships with other pharmacies to expand its distribution network. By collaborating with established pharmacy chains, the company can increase its product availability and reach a wider customer base. This initiative requires careful selection of partners and negotiation of favorable distribution agreements. The goal is to leverage the existing infrastructure and customer base of partner pharmacies to drive sales growth.
- Enhancement of Marketing and Branding: AiXin Life International can invest in enhancing its marketing and branding efforts to increase brand awareness and customer loyalty. Effective marketing campaigns can highlight the quality and benefits of its products, attracting new customers and retaining existing ones. This requires a comprehensive marketing strategy that includes online advertising, social media engagement, and traditional media channels. A strong brand image can differentiate the company from its competitors and drive long-term growth.
What Opportunities Does AIXND Have?
- Expansion of online sales channels.
- Improvement of hotel operations.
- Development of new nutritional products.
- Strategic partnerships with pharmacies.
What Threats Does AIXND Face?
- Intense competition in the Chinese market.
- Changing consumer preferences.
- Regulatory compliance and quality control challenges.
- Economic downturn in China.
What Are AIXND's Competitive Advantages?
- Established presence in the Chinese market since 1987.
- Diversified distribution channels, including pharmacies, sales offices, and online platforms.
- Operation of the Shangyan Hotel provides a diversified revenue stream.
What Does AIXND Do?
AiXin Life International, Inc., established in 1987 and headquartered in Chengdu, China, operates within the consumer defensive sector, specifically in food distribution. The company markets and sells nutritional consumer products and supplements across China. AiXin Life International operates through three segments: Advertising and Products, Pharmacies, and Hotels. The Advertising and Products segment focuses on marketing and selling nutritional products and supplements through various channels. The Pharmacies segment involves selling products through its own pharmacies. The Hotels segment operates the Shangyan Hotel, located in Chengdu. The company's distribution network includes its pharmacies, sales offices, exhibition events, person-to-person marketing, and online platforms. This diversified approach aims to reach a broad customer base across different demographics and geographic locations within China. However, the company faces challenges, as reflected in its negative profit and gross margins.
What Products and Services Does AIXND Offer?
- Markets and sells nutritional consumer products and supplements in China.
- Operates through three segments: Advertising and Products, Pharmacies, and Hotels.
- Sells products through its pharmacies, sales offices, exhibition events, and person-to-person marketing.
- Distributes products online.
- Operates the Shangyan Hotel in Chengdu City, China.
How Does AIXND Make Money?
- Sells nutritional products and supplements through multiple channels, including pharmacies, sales offices, and online platforms.
- Generates revenue from the sale of advertising and products.
- Operates a hotel to generate revenue from accommodation and related services.
What Industry Does AIXND Operate In?
The food distribution industry in China is characterized by intense competition and evolving consumer preferences. Companies like AiXin Life International face challenges from both domestic and international players. The market is driven by increasing health awareness and demand for nutritional products and supplements. However, regulatory compliance and quality control are critical factors for success. AiXin Life International's performance is influenced by its ability to adapt to changing consumer trends and maintain a competitive edge in a fragmented market.
Who Are AIXND's Key Customers?
- Consumers in China seeking nutritional products and supplements.
- Customers of the Shangyan Hotel in Chengdu City.
- Individuals purchasing products through pharmacies, sales offices, exhibition events, and online channels.
Company Profile
AiXin Life International, Inc. operates in the Food Distribution industry within the Consumer Defensive sector. It is headquartered in Chengdu, CN. The company is led by CEO Quanzhong Lin. AIXND has traded publicly since 2008.
AiXin Life International, Inc. Financial Trajectory
AiXin Life International, Inc. (AIXND) reported $328K in revenue for Q4 2025, reflecting 8.5% growth compared to the prior quarter. The company recorded a net loss of $629K, with diluted EPS of $-0.03. Quarter-over-quarter revenue has been mixed, typical for a unknown company operating in Consumer Defensive. Across the four most recent quarters, AIXND averaged $-0.02 in diluted EPS.
ROE 36%Key Financial Metrics
Return on equity for AiXin Life International, Inc. stands at 35.7%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -63.8%, showing how much profit it generates from its asset base. Its free cash flow yield is -25.6%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.12 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -25.5%, the inverse of the P/E and a quick read on earnings relative to price.
F-Score 1/9Financial Health
AiXin Life International, Inc.'s Piotroski F-Score is 1/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -9.52 places it in the distress zone, a signal of elevated financial risk.
AIXND Financials
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in AiXin's growth potential, signaling that executives believe in the company's future.
- Community sentiment has turned positive, with discussions highlighting AiXin's innovative approach to health and wellness products.
- The company has recently expanded its product line, attracting attention from consumers and increasing brand visibility.
- Market developments indicate a growing demand for health-focused solutions, positioning AiXin to capitalize on this trend.
Bear Case
- Concerns over regulatory challenges in the health industry have surfaced, creating uncertainty around AiXin's operational landscape.
- Social sentiment shows skepticism about the company's ability to maintain its growth trajectory amidst increasing competition.
- Recent earnings reports have raised questions about profitability, leading to doubts among investors about long-term viability.
- Some community members express concerns about the sustainability of AiXin's recent product expansions, fearing they may not meet market expectations.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · April 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $327,688 | -$628,789 | -$0.03 |
| Q3 2025 | $301,979 | -$340,461 | -$0.01 |
| Q2 2025 | $460,929 | -$351,505 | -$0.01 |
| Q1 2025 | $398,831 | -$721,708 | -$0.03 |
Based on FMP financials and quantitative analysis
AIXND Latest News
No recent news available for AIXND.
AIXND Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for AIXND.
Price Targets
Wall Street price target analysis for AIXND.
AIXND MoonshotScore
What does this score mean?
The MoonshotScore rates AIXND's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Quanzhong Lin
CEO
Quanzhong Lin is the CEO of AiXin Life International, Inc. He is responsible for managing the company's overall operations and strategic direction. His background includes experience in the consumer products and hospitality industries. He has been instrumental in guiding the company's expansion and diversification efforts. Lin's leadership is focused on improving the company's profitability and market position.
Track Record: Under Quanzhong Lin's leadership, AiXin Life International has focused on expanding its distribution channels and diversifying its product offerings. Key milestones include the operation of the Shangyan Hotel and the development of new nutritional products. However, the company continues to face challenges related to profitability and operational efficiency. Lin's strategic decisions aim to address these challenges and drive long-term growth.
AIXND OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that AiXin Life International may not meet the minimum financial standards required for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure and may not be subject to the same regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. This tier is often associated with higher risk and greater potential for volatility compared to stocks listed on more regulated exchanges.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure due to OTC listing.
- Lower trading volume and wider bid-ask spreads.
- Potential for higher price volatility.
- Increased risk of fraud or manipulation.
- Limited regulatory oversight compared to major exchanges.
- Verify the company's registration and legal status.
- Review available financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Evaluate the management team and their track record.
- Monitor trading volume and price volatility.
- Consult with a financial advisor.
- Understand the risks associated with OTC investing.
- Established presence in the Chinese market since 1987.
- Operation of the Shangyan Hotel provides a diversified revenue stream.
- Focus on nutritional consumer products and supplements.
- Active website and investor relations presence.
Common Questions About AIXND (Consumer Defensive)
What does AiXin Life International, Inc. do?
AiXin Life International, Inc. is a China-based company that markets and sells nutritional consumer products and supplements. It operates through three segments: Advertising and Products, Pharmacies, and Hotels. The company sells products through its pharmacies, sales offices, exhibition events, person-to-person marketing, and online channels. Additionally, it operates the Shangyan Hotel in Chengdu City. The company's business model focuses on providing nutritional products and hospitality services to consumers in China.
What do analysts say about AIXND stock?
As of 2026-03-18, there is no available analyst coverage or consensus on AiXin Life International, Inc. (AIXND) due to its OTC listing and limited financial disclosure. Key valuation metrics such as price targets and earnings estimates are not available. Investors should conduct their own thorough research and consider the risks associated with investing in OTC stocks before making any investment decisions. The company's financial performance and operational efficiency should be carefully evaluated.
What are the main risks for AIXND?
The main risks for AiXin Life International, Inc. include its negative profit and gross margins, which indicate significant operational challenges. The company also faces intense competition in the Chinese market and changing consumer preferences. Additionally, its OTC listing and limited financial disclosure increase investment risk. Investors should be aware of these risks and conduct thorough due diligence before investing in AIXND. The company's financial stability and ability to improve profitability should be carefully monitored.
What are the key factors to evaluate for AIXND?
Evaluate AIXND on fundamentals, analyst consensus, and risk factors. Not financial advice.
How frequently does AIXND data refresh on this page?
AIXND prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven AIXND's recent stock price performance?
AiXin Life International, Inc. (AIXND) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Established presence in the Chinese market. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider AIXND overvalued or undervalued right now?
Valuing AiXin Life International, Inc. (AIXND) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying AIXND?
Before investing in AiXin Life International, Inc. (AIXND), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is limited due to the company's OTC listing.
- Analyst coverage is not available.